Today
Concussion medtech start-up kicks off raise for US expansion
Headsafe hoping to break into the United States healthcare market with its NuroCHEK device, hitting up early-stage investors for $5 million.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Yesterday
G8 Education board faces investor scepticism over Star links
The biggest for-profit operator of childcare also revealed some problems had struck a controversial deal to offload underperforming centres.
- Liam Walsh
New deal! Five V Capital are creatures of Habit
Allied health providers have proved popular – and profitable – for a number of investors, including Quadrant Private Equity, Next Capital and Adamantem Capital.
- Sarah Thompson, Kanika Sood and Emma Rapaport
This Month
Menopause hormone therapy is OK after all, long-term study finds
Since a study in 2002 was called off, women have been reluctant to take hormones. But a new study has reassuring news for women under 60.
- Marlene Cimons
Peloton crashes to record low as CEO quits amid lay-offs
The interactive exercise bike company was a pandemic superstar but is now struggling heavily and laying off 15 per cent of the workforce.
- Mark Gurman
April
- Opinion
- Chanticleer
How Chemist Warehouse can get its deal past the ACCC
Divestments may be needed to get the Chemist Warehouse/Sigma deal over the line, but they don’t look too strenuous.
- Updated
- Anthony Macdonald
Healthscope in $919m writedown as hospital costs jump
One of Australia’s biggest private hospital operators plunged into the red as wage and medical supplies costs climbed, and it booked a big impairment.
- Simon Evans
SA’s Benson Radiology orders adviser beauty parade
Sources said Benson is making about $30 million EBITDA a year.
- Sarah Thompson, Kanika Sood and Emma Rapaport
- Opinion
- Chanticleer
How under the radar I-MED is fighting fit after 20-year PE job
Tucked away in private equity, it is easy to forget about Australia’s biggest imaging company I-MED. But it is worth watching this year; it has a few ideas on the boil.
- Anthony Macdonald
- Opinion
- Chanticleer
Adieu: Ramsay Health Care’s shrinking global ambition
Under-pressure Ramsay Health Care is taking a fresh look at its footprint, which could mean a major change in its strategy. Watch this space.
- Anthony Macdonald
- Opinion
- Chanticleer
Private equity back to clean up its mess at troubled jobs agency
Jobs agency APM’s situation gets more bizarre as it goes looking for another frog to kiss.
- Anthony Macdonald
Andrew Thorburn lands CEO role at HammondCare
At his new job, the one-time NAB CEO’s Christianity is unlikely to be an issue.
- Myriam Robin
- Opinion
- Chanticleer
Ansell shows how to create new interest in an old story
Cheap stock never goes out of fashion. The key for a company is to issue it only occasionally, and make the most of when it does.
- Anthony Macdonald
Medtech Atmo Biosciences shop raise at $55m valuation
Alium Capital Management, Japanese pharmaceuticals giant Otsuka Pharmaceutical and Breakthrough Victoria are set to cornerstone Atmo Biosciences $15 million equity raise.
- Sarah Thompson, Kanika Sood and Emma Rapaport
March
- Opinion
- Chanticleer
Can a vaccine slow down the Cochlear train?
Cochlear is firing for investors, but you have to wonder whether everyone’s getting a bit carried away.
- Anthony Macdonald
Healius in management shake-up after CEO exit
Australia’s No.2 pathology group is cutting costs in a restructure to try to turn around a profit slump, as UBS pushes on with a strategic review.
- Simon Evans
Private equity group CVC walks away from $1.83b APM bid
Rich Lister Megan Wynne built APM from scratch in 1994 into a large player generating fees from helping people find jobs, and has expanded as an NDIS provider.
- Simon Evans
Blood giant CSL works up $US1 billion-plus bond deal; banks mandated
CSL has a host of top-tier investment banks working on the deal, namely Bank of America, Citi, JPMorgan and HSBC.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Healthscope lenders poised to appoint Houlihan Lokey amid restructure
Houlihan Lokey restructuring whiz Jim McKnight is expected to be appointed by lenders at Brookfield’s private hospitals group Healthscope.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Childcare giant G8’s $46m ‘no admission’ settlement
Even with insurance, shareholders will still take a hefty hit after the board decided to settle for “commercial” reasons.
- Updated
- Liam Walsh